Hepatitis C virus and rheumatologic disorders: Many suggestions, few definite conclusions

Journal of Clinical Rheumatology

Volumn 2, Issue 4, 1996, Pages 177-179

  Schultz, Christopher F ^a   Malet, Peter F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8544255619     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/00124743-199608000-00003     Document Type: Article

References (34)

1. Choo QL, Kuo G, Werner AJ, Overby LR, Bradley DVV, Houghton M. Isolation of a c’DNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (Wash DC) 1989;244:7.
2. Booth JCL, Brown JL, Thomas HC. The management of chronic hepatitis C virus infection. Gut 1995;37:449-154.
3. Cumber SC. Chopra S. Hepatitis C: a multifaceted disease. Ann Intern Med 1995:123:615-620.
4. Hoffnagle JH, Di Bisceglie AM. Treatment of chronic type C hepatitis with alpha interferon. Semin Liver Dis 1989;9;259-263.
5. Davis GL, Balart LA, Sehiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989:321:1501-1506.
6. Miescher PA, Huang YP, Izui S. Type II cryoglobulinemia. Semin Hematol 1995:32:80-85.
7. Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Ami Med 1994;96:124-132.
8. Ferri C, Marzo E, Longombardo G, et al. Interferon- alpha in mixed cryoglobulinemia patients: randomized, crossover-controlled trial. Blood 1993;81:1132-1136.
9. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992:327:1490-1495.
10. Misiani R, Bellavita P, Fenili D, et al. Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-756.
11. Navas S, Bosch O, Castillo I, et al. Porphvria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 1995;21:279-284.
12. Stolzel U, Kostler E, Koszka C, et al. Low prevalence of hepatitis C infection in porphvria cutanea tarda in Germany. Hepatology 1995:21:1500-1503.
13. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis iissocialed with hepatitis C virus infection. N Engl J Med 1993;328:465-470.
14. Johnson RJ, Gretch DR, Couser WC, et al. Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 1994;46:1700-1704.
15. Rodnguez-Cuartero A, Garcia-Vera E, Gomez-Carro A. Hepatitis C virus and Sjogren’s syndrome. Infection 1994;22:415-416.
16. Carbon CW, Conn DL, Czaja AJ, et al. Frequents and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-309.
17. Munke II, Stockmann F, Ramadori G. Possible association between Behcet’s syndrome and chronic hepatitis C virus infection. N Engl J Med 1995;332:400-401.
18. Hamuryudan V, Sonsuz A, Yurdakul S. More on hepatitis C virus and Behcet’s syndrome, (Letter) N Engl J Med 1995;333:322.
19. BenEzra D. More on hepatitis C virus and Behcet’s syndrome. (Letter) N Engl J Med 1995;333:322.
20. Oguz A, Sametoglu F, Erdogan S. More on hepatitis C virus and Behcet’s syndrome: (Letter) N Engl J Med 1995;333:322.
21. Castanet J, Lacour JP, Fuzibet JG, et al. Adult Still’s disease associated with hepatitis C virus infection. J Am Acad Dermatol 1994;31:807-808.
22. Ueno Y, Kinoshita R, Kishimoto I, Okamoto S. Polyarthritis associated with hepatitis C virus infection. Br J Rheum 1994;33:289-291.
23. Tanei R, Watanabe K, Nishiyama S. Clinical and histopathologicai analysis of the relationship between lichen pianus and chronic hepatitis C. J Dermatol 1995;22:316-323.
24. Moder KG, Lindor K. Musculoskeletal symptoms in patients with hepatitis C. JCR: J Clin Rheumatol 1996;2:234-236.
25. Barkhuizen A, Schoepflin GS, Bennett RM. Fibromyalgia: a prominent feature in patients with musculoskeletal problems in chronic hepatitis C. A report of 12 patients. JCR: J Clin Rheumatol 1996;2:180-184.
26. Blasini AM, Alonso EJ, Stekman IL, et al. Treatment with a-interferon for hepatitis C virus infection in a palient with polymyositis. JCR: J Clin Jieumatol 1996;2:236-237.
27. D’Amico E, Palazzi C, Fratelli V, Di Matteo L, Di Girolamo G, Consoli G. High prevalence of hepatitis C virus infection in patients with rheumatoid arthritis. JCR: J Clin Rheumatol 1996;2:233-234.
28. Czaja AJ. Chronic active hepatitis: the challenge for a new nomenclature. Ann Intern Med 1993;119:510-517
29. Desmet VJ, Gerber M, Hoofriagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
30. Zignego AL, Ferri C, Giannini C, et al. Hepatitis C virus genotype analysis in patients with type IJ mixed: cryoglobulinemia. Ann Intern Med 1996;124:31-34.
31. DeBeisceglie AM, Conjeevaram HS, Fried MW, et al. Ribaviriri as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1994;123:897-903.
32. Oeisner DH, Caidwell SH, Kim JP. Hepatitis C virus prevalence in a cryptogenic cirrhotic population. (Abstract) Gasrroenterology 1996;110:A1282.
33. Pawltsky J-M, Yahia MB, Andre C, et al. Immnnologkal disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-848.
34. Teli MR, James OFW, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22:1714-1719.